neurosense-tx.com (NRSN) Company Long-Term Loans and Borrowings

Official company branding of NeuroSense Therapeutics Ltd (NRSN)

Israeli biotech startup NeuroSense Therapeutics (NRSN) is exposed to geopolitical threats that could obstruct supplies and clinical trials. The business's financial stability relies critically on the success of new drug tests amid a high capital burn rate, which stands at 0.00. This price chart illustrates the dynamics of the company's debt load. The stability of development is maintained through the use of agile logistics services for the transport of chemical components.

NRSN (neurosense-tx.com) Company Long-Term Debt history from 07/04/2022 to 10/28/2026

NeuroSense Therapeutics Ltd. (NRSN) - metric breakdowns and financial figures

- price and consensus price forecast:
Stock Price NeuroSense Therapeutics Ltd|NRSN - Price Target Chart
- market capitalization data:
Market Value NeuroSense Therapeutics|NRSN - Total Company Value
- book capitalization data:
Net Asset Value per Share NeuroSense Therapeutics|NRSN - Company Book Value|Capitalization to Book Value Ratio neurosense-tx.com|NRSN - Company Total Assets
- debt and liquidity data:
Debt to Capital NeuroSense Therapeutics|NRSN - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital NeuroSense Therapeutics Ltd|NRSN - Company Debts|Debt to Net Assets Ratio NeuroSense Therapeutics|NRSN - Company Long-Term Debt|Short-Term Debt NeuroSense Therapeutics
Comprehensive company analysis:NeuroSense Therapeutics (NRSN)
Mass-produced product of NeuroSense Therapeutics Ltd.

Professional managers utilize fundamental metrics to filter assets, evaluating long-term liabilities as a tool to balance financial stability and investment leverage. This indicator measures the credit portfolio with a maturity exceeding one year, which is critical for NeuroSense Therapeutics (NRSN) when financing R&D and developing ALS therapies, reflecting the company's ability to sustain clinical trials through its long-term debt structure.

Direct competitors

biogen.com - Company Long-Term Debts|Company Long-Term Debt Neurocrine Biosciences, Inc. (NBIX)|RGC: Company Long-Term Loans and Borrowings|Company Long-Term Debt AXSM|ACAD (ACADIA Corp) - Long-Term Debt|Company Long-Term Debt Xenon Pharmaceuticals (XENE)|Company Long-Term Indebtedness vikingtherapeutics.com|Supernus - Company Long-Term Debts|Long-Term Debt Catalyst Pharma CPRX|Company Long-Term Liabilities DNLI (Denali Therapeutics Inc)|Harmony Corp - Company Long-Term Debts|Company Long-Term Debt Biohaven Ltd. (BHVN)|AMLX: Company Long-Term Loans and Borrowings|Company Long-Term Debt TRVI|PRAX (Praxis Precision Medicines Inc) - Long-Term Debt|AVXL: Company Long-Term Debt|Long-Term Debt Volume CeriBell EEG|Prothena - Company Long-Term Debts|Long-Term Debt ALEC (alector.com)|ANNX - Company Long-Term Debt|Omeros Corp - Company Long-Term Indebtedness|Company Long-Term Debt NGNE (Neurogene Corp)|ACIU - Long-Term Debt Volume|Company Long-Term Debts VYGR|Long-Term Debt neumoratx.com|SCLX - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings Tevogen Bio Holdings Inc. (TVGN)|Company Long-Term Liabilities Alpha Cognition|Amount of Long-Term Liabilities cogrx.com (CGTX)|Company Long-Term Debts Inhibikase Therapeutics|Company Long-Term Loans and Borrowings cassavasciences.com SAVA|ASRT (Assertio Therapeutics) - Company Long-Term Debts|COYA: Long-Term Debt|Company Long-Term Debt vistagen.com VTGN|Ovid Therapeutics (OVID) - Company Long-Term Loans and Borrowings|ABOS (Acumen Pharmaceuticals) - Company Long-Term Debts|Company Long-Term Debts CRVO|ATHE - Company Long-Term Debt|Long-Term Liabilities clene.com (CLNN)|PEPG: Company Long-Term Debts|JUNS - Long-Term Debt|Relmada Therapeutics - Company Long-Term Liabilities|annovisbio.com (ANVS) - Company Long-Term Debts|GRCE - Company Long-Term Liabilities|Firefly Neuroscience, Inc. (AIFF) - Amount of Long-Term Liabilities|KLTO: Company Long-Term Debts|Long-Term Debt Volume Reviva Pharmaceuticals, Inc.|Company Long-Term Debts MTVA (MetaVia Inc)|Company Long-Term Liabilities NRXS (neuraxis.com)|Company Long-Term Debt HSDT|Passage Bio Inc. - Long-Term Debt Volume|Neuphoria (NEUP) - Company Long-Term Debt|NERV: Company Long-Term Indebtedness|Company Long-Term Debt Athira Pharma, Inc. ATHA|ADXN (addextherapeutics.com) - Company Long-Term Loans and Borrowings|ALZN: Company Long-Term Debt|Long-Term Debt Volume CYCN|Company Long-Term Debt Protagenic Therapeutics PTIX|Company Long-Term Indebtedness KTTA (pasitheaclinics.com)|CRGT - Company Long-Term Debt|Company Long-Term Indebtedness avenuetx.com ATXI|BCLI (BrainStorm Cell Therapeutics) - Company Long-Term Debts|Cara Therapeutics Inc. (CARA) - Long-Term Debt|CHRO: Company Long-Term Liabilities|ELYM (Eliem Therapeutics Inc.) - Company Long-Term Debts|ITCI - Company Long-Term Debt|Company Long-Term Loans and Borrowings LBPH|Marinus Pharmaceuticals, Inc. - Company Long-Term Debt|Long-Term Debt NKGN (NKGen Biotech Inc)|NRBO - Company Long-Term Debt|Company Long-Term Indebtedness Sage Therapeutics Inc SAGE|SNPX (Synaptogenix, Inc.) - Company Long-Term Debts|trevena.com (TRVN) - Long-Term Debt|VIGL: Company Long-Term Liabilities|WENA (Anew Medical Inc.) - Company Long-Term Debts|CERE - Company Long-Term Debt